Publikationer – Gunilla Enblad

Publikationer i DiVA

Publikationer i PubMed

Ett urval av våra publikationer:

  1. Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy. I Lagerlöf, H Fohlin, G Enblad, B Glimelius, C Goldkuhl,  M Palma, L Åkesson, I Glimelius , D Molin. J Clin Oncol 2022, JCO2102407. 
  2. Plasma proteome profiling reveals major differences between acute leukemia/malignant lymphoma patients and controls. A Abu Sabaa, Q Shen, E Bergfelt Lennmyr, AP Enblad, G Gammelgård, A Hein, E Freyhult, M Kamali-Moghaddam, M Höglund, G Enblad, A Eriksson. N Biotechnol. 2022, 71:21-29.
  3. Age is the most important survival predictor in DLBCL patients achieving EFS24, a Swedish population-based study. A Abu Sabaa, C Mörth, S Hasselblom, G Hedström, M Flogegård, M Stern, P-O Andersson, I Glimelius, G Enblad. Br J Haematol. 2021, 193(5):906-914.
  4. Plasma proteome profiling of cardiotoxicity in patients with diffuse large B-cell lymphoma. C Mörth, A Abu Sabaa, E Freyhult, C Christersson, J Hashemi , N Hashemi, M Kamali-Moghaddam, D Molin, M Höglund, A Eriksson, G Enblad. Cardiooncology 2021, 7(1):6. 
  5. Immune-Proteome Profiling in Classical Hodgkin Lymphoma Tumor Diagnostic Tissue. A R Gholiha, P Hollander, L Löf, A Larsson, J Hashemi, J Mattsson Ulfstedt, D Molin, R-M Amini, E Freyhult, M Kamali-Moghaddam, G Enblad. Cancers (Basel). 2021, 14(1):9.
  6. Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome. R-M Amini, V Ljungström, M Abdulla, L Cavelier, T Pandzic, P Hollander, G Enblad, P Baliakas. Am J Hematol. 2020 Jul 6. doi: 10.1002/ajh.25927. Online ahead of print.
  7. Autoimmune disease in patients with diffuse large B-cell lymphoma: occurance and impact on outcome. C Mörth, A Valachis, A Abu Sabaa, G Hedström, M Flogegård, E Baecklund, G Enblad. Acta Oncol. 2019, 58(8):1170-1177.
  8. Does the omission of vincristine in patients with diffuse large B-cell lymphoma affect treatment outcome? C Mörth, A Valachis, A Abu Sabaa, D Molin, M Flogegård, G Enblad. Ann Hematol. 2018, 97(11):2129-2135.
  9. A Phase I/IIa Trial Evaluating Safety, Efficacy, And Immune Status Post 3rd Generation Car T Cell Therapy. G Enblad, H Karlsson, G Gammelgård, J Wenthe, T Lövgren, R-M Amini, K I Wikstrom, M Essand, B Savoldo, H Hallböök, M Höglund, G Dotti, M K Brenner, H Hagberg, A Loskog. Clin Cancer Res. 2018 2018, 24(24):6185-6194.
  10. Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma. Johnson P, Federico M, Kirkwood A, Fosså A, Berkahn L, Carella A, d'Amore F, Enblad G, Franceschetto A, Fulham M, Luminari S, O'Doherty M, Patrick P, Roberts T, Sidra G, Stevens L, Smith P, Trotman J, Viney Z, Radford J, Barrington S. N Engl J Med. 2016, 374(25):2419-29.

Senast uppdaterad: 2023-02-15